日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway.

长链非编码RNA STMN1P2通过hnRNPU-EZH2-TARF6-MALT1-caspase-1通路抑制细胞焦亡,从而促进乳腺癌对阿霉素的耐药性。

Jin You-Ping, Xu Bu-Jie, Zhang Xiu-Fen, Wang Xue, Wang Li, Li Lu-Ying, Chen Shu-Yi, Zhu Ping, Zhi Xiu-Ling, Lv Lei, Wang Chao-Fu, Wang Zheng-Lin, Sun Yang-Bai, Zhou Ping

Astragaloside IV targets TUBB4B to inhibit proliferation and promote apoptosis of pituitary tumor cells via the STMN1/ERK pathway.

黄芪甲苷 IV 通过 STMN1/ERK 通路靶向 TUBB4B,抑制垂体肿瘤细胞增殖并促进其凋亡。

Li Jiale, Qu Yufei, Zhang Wenge, Yang Zexu, Zeng Yangdong, Xu Jisheng, Xie Kuncen, Liu Qi

Novel therapeutic strategy targeting STMN1 using chlorambucil-conjugated pyrrole-imidazole polyamide in small cell lung cancer

利用氯苯丁酸氮芥偶联吡咯-咪唑聚酰胺靶向STMN1的新型治疗策略治疗小细胞肺癌

Yoshikawa, Ryohei; Watanabe, Takayoshi; Ohtaki, Yoichi; Bando, Toshikazu; Sugiyama, Hiroshi; Araki, Takuya; Yashima, Hideaki; Erkhem-Ochir, Bilguun; Okami, Haruka; Dorjkhorloo, Gendensuren; Shioi, Ikuma; Nagashima, Toshiteru; Kawatani, Natsuko; Yazawa, Tomohiro; Narusawa, Eiji; Kosaka, Takayuki; Kawashima, Osamu; Kamiyoshihara, Mitsuhiro; Minna, John D; Girard, Luc; Shirabe, Ken; Nagase, Hiroki; Shimizu, Kimihiro; Yokobori, Takehiko

Identification of STMN1 as a lactylation‑related driver of lung cancer progression using Mendelian randomization

利用孟德尔随机化方法鉴定STMN1为肺癌进展的乳酸化相关驱动因子

Cai, Yifan; Zhong, Yucheng; Wang, Honglin; Zhu, Shuang; Huang, Fang; Zhang, Qiuyue; Hu, Shaobo

Synergistic effect study on the co-delivery of paclitaxel and SiRNA targeting STMN1 based on MPDA nanoparticles in the therapy of ovarian cancer

基于MPDA纳米颗粒的紫杉醇与靶向STMN1的siRNA共递送在卵巢癌治疗中的协同效应研究

Qian, Xueqian; Yuan, Yi; Zhang, Yaning; Li, Manlin; Wang, Xiaotong; Li, Weikai; Wen, Ling; Duan, Guangxin; Han, Yangyang

STMN1-IGFBP5 axis induces senescence and extracellular matrix degradation in nucleus pulposus cells: In vivo and in vitro insights

STMN1-IGFBP5轴诱导髓核细胞衰老和细胞外基质降解:体内和体外研究结果

Li, Lei; Zhang, Guangzhi; Yang, Zhili; Cao, Zhenyu; Wang, Dongxin; Kang, Xuewen

A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1/PRDX1 as therapeutic targets

乳酸化-铁死亡串扰基因特征可预测肝细胞癌的预后,并揭示STMN1/PRDX1作为治疗靶点

Meng, Jiali; Liang, Chunyan; Li, Ling; Huang, Qiqi; Huang, Weimei; Wang, Rensheng; Li, Xiaolong

Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer

STMN1表达及其在乳腺癌新辅助治疗疗效中的预后作用

Li Qian #,Zhu Cairong #,Liao Yongdong #,Li Quan,Zhong Haihu,Zhu Xiaofeng,Ye Xuan,Chen Yongcheng,Chen Kai,Lu Guanming,Li Jie

circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC.

circFOXK2 通过 PABPC1 稳定 STMN1 mRNA,从而促进 NSCLC 的进展

Chen Wei, Zhao Weijun, Wu Xianqiao, Fang Tianzheng, Chen Ziyuan, Chen Zixuan, Su Wenmin, Zhao Xiaodong, Hu Yuanyuan, Xu Yiping, Fang Shuai, Zhou Chengwei

STMN1 regulates the stemness of gastric cancer cells by binding to HN1L to activate the STAT3 signaling pathway

STMN1通过与HN1L结合激活STAT3信号通路来调控胃癌细胞的干性。

Chunyang Wei,Xing Zhang,Hao Li,Jianzhong Gu,Fei Xue,Wenna Xie,Gang Ji